About Us

About PlasmaCap EBA™


PlasmaCap EBA™ is an innovative technology for efficient capture of plasma proteins at high yields and purities. PlasmaCap EBA™ uses proprietary affinity adsorbents in expanded bed adsorption (EBA) chromatography to capture plasma proteins directly from plasma or fractionated plasma materials. Through substantial development efforts, PlasmaCap EBA™ has been able to achieve significant capture yields for major plasma proteins of value. PlasmaCap EBA™ is owned by Therapure Biopharma Inc., which has developed the technology through its Therapure Biologics division to enhance its offerings to plasma fractionators, plasma protein manufacturers, and biopharma manufacturers.


Therapure Biologics, a division of Therapure Biopharma Inc., focuses on the development of a portfolio of its own plasma-derived pharmaceutical products using its proprietary technology, PlasmaCap EBA™ and building on Therapure’s biomanufacturing capabilities and plasma protein expertise. Therapure Biologics is able to provide improved efficiencies and unprecedented precision in the extraction of plasma proteins. Our mission at Therapure Biologics is to produce a reliable supply of safe and effective plasma protein therapeutics by using new technology to optimize their production.

About Therapure Biopharma Inc.


Therapure Biopharma Inc. is an integrated biopharmaceutical company focused on complex biological therapeutics and technologies that can provide new options for patient care. It is comprised of Therapure Biomanufacturing, the award-winning Contract Development and Manufacturing (CDMO) division and Therapure Innovations, the proprietary drug pipeline and platform technology research and development division. Therapure Biopharma Inc.’s 130,000 sq. ft. cGMP facility includes biomanufacturing, research and quality-control laboratories and is built to meet FDA (USA), HPFB (Canada), EMA (Europe) and MHRA (UK) standards.

plasma-cap therapurebio-plasmacap

Disclaimer | Privacy Policy | Accessibility | Sitemap

PlasmaCap EBA is a trademark of Therapure Biopharma Inc.

Copyright ©2013 Therapure Biopharma Inc.